SGLT-2 inhibitors affect on plasma renin activity and aldosterone concentration with the alteration of urinary sodium excretion and haematocrit in type 2 diabetes

被引：0
|
作者：
Ishizuka, T. [1 ]
Mori, I. [1 ]
Fujioka, K. [1 ]
Fuwa, M. [1 ]
Tangiku, M. [1 ]
Andoh, D. [1 ]
Maruyama, T. [1 ]
Yamada, K. [1 ]
机构：
[1] Gifu Municipal Hosp, Ctr Gen Internal Med & Rheumatol, Gifu, Japan
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
902
引用
收藏
页码：S418 / S418
页数：1
相关论文
共 50 条
  • [41] EFFECTS OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS ON ANEMIA IN PATIENTS WITH TYPE 2 DIABETES
    Yang, Ai-Yu
    Chen, Hung-Chun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1007 - I1008
  • [42] PLASMA-RENIN ACTIVITY, PLASMA-RENIN SUBSTRATE AND URINARY ALDOSTERONE EXCRETION IN MENSTRUAL-CYCLE IN RELATION TO CONCENTRATION OF PROGESTERONE AND ESTROGENS IN PLASMA
    SUNDSFJORD, JA
    AAKBAAG, A
    ACTA ENDOCRINOLOGICA, 1972, 71 (03): : 519 - +
  • [43] Safety of sodium-glucose transporter 2 (SGLT-2) inhibitors in patients with type 2 diabetes: a meta-analysis of cohort studies
    Li, Chun Xing
    Liu, Tian Tian
    Zhang, Qian
    Xie, Qing
    Geng, Xu Hua
    Man, Chun Xia
    Li, Jia Yi
    Mao, Xin Ying
    Qiao, Yue
    Liu, Hua
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [44] SGLT-2 INHIBITORS AS ADJUNCT THERAPY IN TYPE 1 DIABETES: REASON FOR HOPE AND CAUTION
    Lane, Wendy
    ENDOCRINE PRACTICE, 2016, 22 (03) : 371 - 373
  • [45] Halting the progression of chronic kidney disease; an audit of the use of renin-angiotensin-aldosterone blockers and SGLT-2 inhibitors
    Teh, Jia Wei
    Harris, Luke
    Corcoran, Niamh
    Lappin, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2399 - I2399
  • [46] Halting the progression of chronic kidney disease; an audit of the use of renin-angiotensin-aldosterone blockers and SGLT-2 inhibitors
    Teh, Jia Wei
    Harris, Luke
    Corcoran, Niamh
    Lappin, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [47] Effect of SGLT-2 Inhibitors on an impaired ventricular Repolarization Retrospective Study of Patients with Type 2 Diabetes
    Jecht, M.
    DIABETOLOGE, 2017, 13 (08): : 583 - 585
  • [48] DIABETIC KETOACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES RECENTLY COMMENCED ON SGLT-2 INHIBITORS: AN ONGOING CONCERN
    Ahmed, Mohamed
    McKenna, Malachi J.
    Crowley, Rachel K.
    ENDOCRINE PRACTICE, 2017, 23 (04) : 506 - 508
  • [49] Examination for the Alterations of Serum and Urinary Sodium Levels after Treatment with SGLT2 Inhibitors in Type 2 Diabetes
    Ishizuka, Tatsuo
    Asano, Motochika
    Fujioka, Kei
    Kitada, Yoshihiko
    Andoh, Daiki
    Maruyama, Takako
    Yamada, Kouji
    DIABETES, 2016, 65 : A313 - A313
  • [50] SGLT-2 Inhibitors and the Risk of Community-Acquired Pneumonia in Patients with Type-2 Diabetes
    Brunetti, Vanessa
    Reynier, Pauline
    Azoulay, Laurent
    Yu, Oriana H. Y.
    Ernst, Pierre
    Platt, Robert W.
    Filion, Kristian B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 37 - 38
12345